We are recruiting a motivated Postdoctoral Fellow @CincyChildrens to lead a project on mitochondrial metabolism in thermogenic adipocytes with strong intersections with cardiovascular biology and whole-body metabolism. Come join us! cincinnatichildrens.wd5.mywo…
I am delighted to share that our paper about the widely used UCP1-CreEvdr transgene is out in Nature communications!🎉 I am thankful to @JSG_Lab for pushing through to make an impact to the field. This wouldn’t be possible without all the co-authors, I am very thankful to all!😄
Happy to share the final version of our paper describing that the widely used Ucp1-CreEvdr transgene unfortunately elicits complex developmental and metabolic phenotypes. This work was mainly driven by @ManasiHalurkar (now a PhD student at Purdue). nature.com/articles/s41467-0…
Our new paper, "NK2R control of energy expenditure and feeding to treat metabolic diseases," is out today in @Nature.
Here we identify a single receptor that can both peripherally increase energy expenditure and centrally suppress appetite.
nature.com/articles/s41586-0…
1/12 🧵👇
Check out this blog explaining our recent paper @CellRepMed explaining the capabilities of adipose tissue CD271+ cells to induce revascularization in limb ischemia. @CincyChildrens@OtoInoue@heewlim
A specific type of stem cell transplant shows early-stage promise at preventing limb amputations caused by #diabetes and other conditions, according to new findings from Cell Reports Medicine. Congrats to Drs. Inoue and Sanchez-Gurmaches. Learn more: scienceblog.cincinnatichildr…
To investigate the therapeutic potential of CD271+ cells in humans, we evaluated data from an adipose tissue limb ischemia cell therapy trial. We observed a striking correlation between successful recovery and the number of CD271+ progenitors injected.
Analyzing subcutaneous fat samples from donors, we found that the number and angiogenic capacity of CD271+ progenitors are strikingly reduced in insulin-resistant donors. Of note, people with insulin resistance are at higher risk of limb ischemia making it a bigger problem.
Using in vivo transplantation into a surgical mouse model of limb ischemia, we show that CD271+ progenitors have high therapeutic capacities for limb ischemia including long-term engraftment, augmented tissue regeneration and back to normal recovery of blood flow.
In this manuscript, we show that CD271+ progenitors in adipose tissue have a prominent angiogenic gene profile over other routinely used cell sources and encompass the majority of angiogenic gene expression within the mesenchymal cells in the adipose tissue.
This work was lead by @OtoInoue and it is a collaboration between @CincyChildrens and @KanazawaUniv_O. Glad to work with Dr Usui and Dr Takamura on this exciting project. Many thanks to @heewlim.
Happy to share our paper on the very exciting therapeutic potential of adipose tissue derived CD271+ progenitors on limb ischemia published @CellRepMed today. cell.com/cell-reports-medici…
The video highlighting the key steps of our protocol to measure de novo lipogenesis with @martina5wallace is now available! Hope you find it useful. jove.com/video/64219
Our findings indicate that the hemizygous Ucp1-CreEvdr mice exhibit substantial brown and white fat tissue dysregulation affecting cold response. Homozygous Ucp1-CreEvdr mice also display high mortality, growth defects, and craniofacial abnormalities.
New preprint from the lab! Here we describe that the the widely used Ucp1-CreEvdr transgene unfortunately elicits complex developmental and metabolic phenotypes. @CincyChildrensbiorxiv.org/content/10.1101/…
This work was driven by @ManasiHalurkar (now a PhD student at Purdue)